Polyneuron is in the top5 start-up teams at the Science4Life start-up competition in Germany.
In other news
-
General
Polyneuron has obtained the orphan drug designation from the European … [read on]
EMA Orphan Drug Designation for PN-1007 -
General
Polyneuron publishes top PN-1007 in vivo data in the renowned … [read on]
PN-1007 article published in PNAS -
Awards
Polyneuron is proud to announce that it has obtained the … [read on]
CTI Start-up Label -
Awards
Polyneuron is listed Top5 among the best Swiss Biotech Startups … [read on]
Top5 Swiss Biotech Startup -
Awards
Polyneuron got selected out of more than 120 European neuroscience … [read on]
Brain Forum Innovation Award -
Financing
Polyneuron announced it has completed a seed financing round raising … [read on]
Polyneuron completes seed financing round -
General
Polyneuron is one of the 25 winners of the renowned … [read on]
IMD StartUp Competition -
General
We are proud to announce that Polyneuron is ranked 39th … [read on]
Polyneuron is listed in the TOP 100 of the best Swiss Startups 2015 -
Awards
Venture kick Phase 3 “Kick-start your startup”: Polyneuron wins the … [read on]
Venture Kick Phase 3 -
General
Ruben Herrendorff, CEO of Polyneuron, is part of the Swiss … [read on]
Swiss National Startup Team 2015 -
General
Polyneuron Pharmaceuticals AG: Polyneuron is proud to announce its incorporation. [read on]
We are corporate now -
Awards
Venture Kick Phase 2 “Present your business case”: Polyneuron convinced … [read on]
Venture Kick Phase 2 -
Awards
Venture Kick Phase 1 “Pitch your business idea” : Polyneuron … [read on]
Venture Kick Phase 1 -
Awards
Polyneuron is in Venture TOP4 business plan winners … [read on]
Venture business plan winners -
Awards
In the framework of its program “support to start-ups”, the … [read on]
Neurex Award